Mai Capital Management Bio Atla, Inc. Transaction History
Mai Capital Management
- $10.1 Billion
- Q3 2024
A detailed history of Mai Capital Management transactions in Bio Atla, Inc. stock. As of the latest transaction made, Mai Capital Management holds 452,092 shares of BCAB stock, worth $266,734. This represents 0.01% of its overall portfolio holdings.
Number of Shares
452,092
Previous 477,619
5.34%
Holding current value
$266,734
Previous $654,000
21.56%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding BCAB
# of Institutions
65Shares Held
17.4MCall Options Held
500Put Options Held
33.5K-
Israel Englander Millennium Management LLC | New York, Ny2.66MShares$1.57 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.52MShares$1.49 Million0.38% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.89MShares$1.11 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.86MShares$1.1 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA874KShares$515,7040.13% of portfolio
About BioAtla, Inc.
- Ticker BCAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,304,100
- Market Cap $21.4M
- Description
- BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...